Moderna COVID-19 Vaccine Data Bring Multivalent Vs. Monovalent Debate Into Focus

 
• By Alaric DeArment
  
Moderna announced Phase II/III data for its bivalent mRNA-1273.211 vaccine candidate • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip